Excel Medical News & Press

Excel Medical’s WAVE Clinical Platform Receives FDA Clearance

The Patient Surveillance and Predictive Algorithm Platform is the First of Its Kind to Be Cleared by the FDA

Jupiter, Fla. – January 8, 2018 – Excel Medical launches the first FDA-cleared patient surveillance system. The WAVE Clinical Platform is the first of its kind cleared for marketing. The WAVE Clinical Platform is an always-on remote monitoring platform that displays near real-time clinical views of physiologic and medically relevant data including waveforms and alarms for at-risk patients across hospital workstations, mobile devices and inside electronic medical records. WAVE automatically calculates risk, giving an at-a-glance early warning of patient deterioration up to six hours in advance of when clinicians would otherwise notice—and while there is still time to prevent further deterioration. In fact, while using the Visensia Safety Index, WAVE’s first FDA-cleared predictive algorithm, UPMC went from six unexpected deaths in their control group to zero. * “Everything we do as an organization aligns toward and supports the goal of eradicating unexpected deaths in hospitals,” says Lance Burton, General Manager of Excel Medical. “People may say zero unexpected deaths is unattainable. We say anything other than zero is unconscionable.” For more than a decade, Excel Medical’s products have been battle-tested in over 80 percent of the top academic medical centers, as well as by researchers and innovation partners. Now, with the clearance of the WAVE Clinical Platform, the company sits on the edge of a major opportunity to fulfil the promise of predictive healthcare. “We look forward to bringing other revolutionary predictive algorithms to the WAVE platform soon, many of which are currently under development,” adds Burton.

About Excel:

Excel Medical’s technologies were designed with one goal in mind—to eradicate unexpected deaths in hospitals. There are more than 400,000 unexpected deaths in U.S. hospitals annually making it the nation’s third-leading cause of death—behind heart disease and cancer. Excel Medical’s “True North” is to make predictive analytics an actionable process, “predicting the preventable™”, making it possible to achieve zero unexpected hospital deaths. Excel Medical was founded in 1995, and its products/services are used by more than 80 percent of the top academic medical centers and children’s hospitals in the United States. Excel Medical Electronics, LLC, has multiple high-profile partners including IBM Watson, OBS Medical and EPIC. It is a privately-held company headquartered in Jupiter, FL, with customers throughout North America, Europe, Australia and Asia. www.Excel-Medical.com. All referenced product and company names are trademarks™ or registered® trademarks of their respective holders.

*Study available upon request: “Cardiorespiratory instability before and after implementing an integrated monitoring system,” by 6 authors including Marilyn Hravnak, University of Pittsburgh and Michael A. Devita, New York City Health and Hospitals Corporation.

Download PDF

Topics: Press Releases